UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005020 |
|---|---|
| Receipt number | R000005957 |
| Scientific Title | A Phase II study of Aprepitant in patients receiving chemotherapy included carboplatin for gynecological canncer. |
| Date of disclosure of the study information | 2011/02/04 |
| Last modified on | 2018/08/11 06:46:07 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/02/03 22:56:21 | ||
| 2 | Update | 2018/08/11 06:31:32 | Primary outcomes Key secondary outcomes |
|
| 3 | Update | 2018/08/11 06:42:58 | Randomization Control |
|
| 4 | Update | 2018/08/11 06:44:58 | TEL Last name of contact person Last name of contact person TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2018/08/11 06:46:07 | Recruitment status Publication of results URL related to results and publications |
